5IR1
Cetuximab Fab in complex with 3-bromophenylalanine meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2011-07-14 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.040, 82.510, 211.540 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 34.225 - 2.482 |
R-factor | 0.1657 |
Rwork | 0.163 |
R-free | 0.21490 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.180 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX ((1.10_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 34.225 | 2.550 |
High resolution limit [Å] | 2.480 | 2.480 |
Number of reflections | 40296 | |
<I/σ(I)> | 30.1 | 8.9 |
Completeness [%] | 99.4 | |
Redundancy | 5.8 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citric acid, 0.1 M sodium hydrogen phosphate, 0.4 M potassium hydrogen phosphate, 1.6 M sodium dihydrogen phosphate |